Cargando…

Hairy Cell Leukemia Presenting with Isolated Skeletal Involvement Successfully Treated by Radiation Therapy and Cladribine: A Case Report and Review of the Literature

We describe an unusual case of hairy cell leukemia (HCL) in a 55-year-old male presenting with isolated skeletal disease as the initial manifestation without abnormal peripheral blood counts, bone marrow involvement, or splenomegaly. To the best of our knowledge, there have been only two previous re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yonal-Hindilerden, Ipek, Hindilerden, Fehmi, Bulut-Dereli, Sanem, Yıldız, Eren, Dogan, Ibrahim Oner, Nalcaci, Meliha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695657/ https://www.ncbi.nlm.nih.gov/pubmed/26788382 http://dx.doi.org/10.1155/2015/803921

Ejemplares similares

Hairy cell leukemia followed by polycythemia vera: report of the first case
por: Ipek, Yonal-Hindilerden, et al.
Publicado: (2016)

MALT lymphoma of the left biceps muscle: a rare case with an interesting presentation
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2016)

Aleukemic Leukemia Cutis Manifesting with Disseminated Nodular Eruptions and a Plaque Preceding Acute Monocytic Leukemia: A Case Report
por: Yonal, Ipek, et al.
Publicado: (2011)

Primary Mediastinal Large B-Cell Lymphoma As an Incidental Finding: Report of a Case
por: Yönal-Hindilerden, İpek, et al.
Publicado: (2018)

Primary B-Cell Mucosa-Associated Lymphoid Tissue Lymphoma of the Hard Palate and Parotid Gland: Report of One Case and Review of the Literature
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2016)

Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms
por: Yönal-Hindilerden, İpek, et al.
Publicado: (2023)

Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases
por: Hindilerden, Fehmi, et al.
Publicado: (2017)

Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen
por: Hindilerden, Fehmi, et al.
Publicado: (2022)

Effects of Mutational Combinations on Philadelphia-Negative Myeloproliferative Neoplasms
por: Ipek, Yonal-Hindilerden, et al.
Publicado: (2017)

A misleading presentation of T cell/histiocyte rich B-cell lymphoma mimicking osteomyelitis
por: Özpolat, Tahsin, et al.
Publicado: (2018)

A Rare Cause of Unexplained Refractory Iron Deficiency Anemia: Unicentric Plasma-Cell Type Castleman’s Disease
por: Kalayoğlu Beşışık, Sevgi, et al.
Publicado: (2016)

The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2016)

Budd-Chiari Syndrome: An Unusual Complication of AL Amyloidosis
por: Tiryaki, Tarık Onur, et al.
Publicado: (2020)

Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection
por: Hindilerden, Fehmi, et al.
Publicado: (2021)

Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin’s Lymphoma
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2021)

Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Results from a Single Center, 1993-2011
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2017)

A Case with Hepatic Involvement Mimicking Metastatic Disease in Multiple Myeloma
por: Erciyestepe, Mert, et al.
Publicado: (2020)

Immune Thrombocytopenia in a Very Elderly Patient With Covid-19
por: Hindilerden, Fehmi, et al.
Publicado: (2020)

Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case
por: Hindilerden, Fehmi, et al.
Publicado: (2020)

Severe Autoimmune Hemolytic Anemia in COVID-19 İnfection, Safely Treated with Steroids
por: Hindilerden, Fehmi, et al.
Publicado: (2020)

The co-presence of deletion 7q, 20q and inversion 16 in therapy-related acute myeloid leukemia developed secondary to treatment of breast cancer with cyclophosphamide, doxorubicin, and radiotherapy: a case report
por: Yonal, Ipek, et al.
Publicado: (2012)

The Burden of JAK2V617F Mutated Allele in Turkish Patients With Myeloproliferative Neoplasms
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2015)

Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2015)

Plasmacytoma of the Nasolacrimal Duct Simulating Dacryocystitis: An Uncommon Presentation for Extramedullary Relapse of Multiple Myeloma
por: Kalayoglu-Besisik, Sevgi, et al.
Publicado: (2012)

Comprehensive mastocytosis data analysis from a single center
por: Tiryaki, Tarık Onur, et al.
Publicado: (2023)

A case of chronic lymphocytic leukemia with massive ascites
por: Yonal, Ipek, et al.
Publicado: (2012)

Complete recovery of pyoderma gangrenosum after successful treatment of underlying hairy cell leukemia with cladribine
por: Tombak, Anıl, et al.
Publicado: (2015)

P939: THE RELATIONSHIP OF BONE MARROW FIBROSIS WITH EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
por: Konyaoglu, Hilal, et al.
Publicado: (2023)

Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine
por: Otieno, Steve B, et al.
Publicado: (2022)

WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?
por: ERDEM, Simge, et al.
Publicado: (2021)

Efficacy and Safety of Cladribine: Subcutaneous versus Intravenous Administration in Hairy Cell Leukemia Patients
por: Khorshid, Ola, et al.
Publicado: (2015)

Treatment of Classic Hairy Cell Leukemia: Targeting Minimal Residual Disease beyond Cladribine
por: Bohn, Jan-Paul, et al.
Publicado: (2022)

Severe Systemic Rash in the Treatment of Hairy Cell Leukemia with Cladribine: Case Report and Literature Review
por: Dong, Huijie, et al.
Publicado: (2020)

Skeletal involvement of hairy cell leukemia
por: Durot, Eric, et al.
Publicado: (2018)

Outcome of hairy cell leukemia patients treated with cladribine – a 10-year single-center experience in Pakistan
por: Zahid, Mohammad Faizan, et al.
Publicado: (2019)

A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia
por: Broccoli, Alessandro, et al.
Publicado: (2022)

Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience
por: Özbalak, Murat, et al.
Publicado: (2022)

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant
por: Chihara, Dai, et al.
Publicado: (2021)

Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study
por: Pagano, Livio, et al.
Publicado: (2022)

Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis
por: Yönal, İpek, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d49h28sgsol5ajaru5u0ul84e4